Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find out if a Chinese herbal cream is effective in treating HSIL (high-grade squamous intraepithelial lesions, also known as HGAIN, or high-grade anal intraepithelial neoplasia).


Clinical Trial Description

The purpose of this study is to test a new noninvasive topical cream, AIJP (Arnebia Indigo Jade Pearl), for treatment of precancerous anal lesions in order to prevent their progression to anal cancer. AIJP is a topical Chinese herbal cream that has been specifically designed to treat people with the cancer precursor lesions caused by human papillomavirus (HPV). In general, HPV infection is a key factor in development of cervical, anal and vulvar cancers. People with HIV are especially vulnerable to develop anal cancer associated with HPV. It is known that prior to development of anal cancer a person develops a precancerous condition known as a high-grade squamous intraepithelial lesion (HSIL). Treatment of the HSIL can prevent progression to anal cancer. Current therapies for HSIL and anal cancer are highly invasive. A new effective noninvasive topical therapy for precancerous HSIL could have a high impact on prevention of anal cancer. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00622440
Study type Interventional
Source University of California, San Francisco
Contact
Status Completed
Phase Phase 2
Start date May 14, 2008
Completion date December 12, 2012

See also
  Status Clinical Trial Phase
Completed NCT01717391 - [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers Phase 2
Active, not recruiting NCT03018418 - Proton Therapy in Reducing Toxicity in Anal Cancer Phase 2
Enrolling by invitation NCT02526953 - Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients Phase 3
Recruiting NCT05578820 - Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid Phase 1
Recruiting NCT02384005 - The Feasibility of Self or Partner-assisted Digital Anal Exam Screening N/A
Completed NCT00428285 - Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men Phase 2
Completed NCT00107679 - A Study of Anal Cancer Development in HIV Infected People N/A
Terminated NCT01408407 - Alkagin Paste in the Prevention of Radiation Dermatitis Phase 2
Completed NCT00799474 - Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination N/A
Completed NCT03202992 - Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection Phase 1
Completed NCT00000764 - Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. Phase 1